SCHEMBL24350189

SCHEMBL24350189

Cc1ccc(Nc2sc3ncccc3c2C(=O)OC(C)(C)C)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
ATM Q13315 1/20 0.40
CISD2 Q8N5K1 1/20 0.39
CLK1 P49759 1/20 0.39
SYK P43405 1/20 0.36
TP53 P04637 1/20 0.36
CSF1R P07333 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
PIP4K2A P48426 1/20 0.35
PIP4K2C Q8TBX8 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAP2K2 P36507 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20564894 0.89 MAP2K1 (0.43) CLK1MAP2K2MAP2K1FLT1MKNK1
SCHEMBL24350196 0.86 ATM (0.44) KDM4EATMCLK1CSF1RNPC1
SCHEMBL24349947 0.85 CISD2 (0.40) KDM4ECISD2SYKCSF1RLMNA
SCHEMBL24349945 0.85 ATM (0.43) KDM4EATMCLK1CSF1RNPC1
SCHEMBL24349922 0.83 CISD2 (0.40) CISD2SYKCSF1RMAPTMAP2K2
SCHEMBL24349753 0.79 MAP2K1 (0.47) MAP2K2MAP2K1
SCHEMBL29302059 0.79 KDM4E (0.41) KDM4ECISD2SYKCSF1RCOMT
SCHEMBL4109917 0.79 MAP2K1 (0.45) KDM4ECLK1TP53LMNACYP1A2
SCHEMBL4109923 0.78 MAP2K1 (0.56) KDM4ECLK1NPC1RAB9ALMNA
SCHEMBL4127775 0.78 CLK1 (0.50) KDM4EATMCLK1TP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4233834-A2 ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF BIRTHMARKS NFlection Therapeutics, Inc. (US) 2023-08-30 EP disclosed
EP-3624795-B1 FUSED HETEROAROMATIC-ANILINE COMPOUNDS FOR TREATMENT OF DERMAL DISORDERS NFLECTION THERAPEUTICS INC (US) 2022-04-20 EP disclosed